INS and gestational diabetes: At baseline, 42.8% of participants in the GDM group were treated with diet therapy, while 57.2% of participants were treated with insulin therapy. Biochemical parameters of FPG, HBA1C, HOMA IR, and N-CML were statistically different between both groups.